… Cr/CysC ratio may be a surrogate marker of sarcopenia in patients with IPF. Furthermore, it is
… determine whether the Cr/CysC ratio can be used to detect sarcopenia in patients with IPF. …

… surgical outcomes and long-term survival of patients with gastric cancer. Serum creatinine/…
as a surrogate marker for sarcopenia but has not been adequately studied in patients with …

… Sarcopenia is common in patients with chronic obstructive pulmonary disease (COPD). … as
a surrogate marker for sarcopenia but has not been adequately studied in patients with COPD…

… could be used as a surrogate marker for sarcopenia because Cre is affected … patients with
type 2 diabetes, we investigated the association between the Cre/CysC ratio and sarcopenia…

… Surrogate markers of sarcopenia had a poor predictive profile for postoperative mortality
after AAA repair in our sample. However, PMD stood out as an independent predictor of long-…

… (ALT) levels are accepted surrogate markers of sarcopenia and related frailty. We aimed
to evaluate the potential association of these markers with NSCLC patients’ survival. …

… sarcopenia. Survival analyses, contingent on different surrogate markers of muscle mass and
sarcopenia… Results: We enrolled 815 patients with CRC (522 male and 293 female patients…

… This study aimed to elucidate a surrogate marker of sarcopenia in patients with liver … with
sarcopenia and could be a useful surrogate marker to predict sarcopenia in patients with LC. …

… The aim of this study was to investigate whether MPM status could be used as (a) a surrogate
marker of sarcopenia in CRC patients and (b) a preoperative predictor of complications …

… the suitability of BIA-measured FFMI as a simple surrogate marker of the ASMI and
calculated the optimal FFMI cutoff value for low muscle mass screening to diagnose sarcopenia. …